Paul D Robinson Selected Research

Paul D Robinson Research Topics

Disease

12	Asthma (Bronchial Asthma) 11/2023 - 12/2010
9	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 08/2009
4	Infections 01/2023 - 01/2017
3	Lung Diseases (Lung Disease) 09/2023 - 12/2021
3	Inflammation (Inflammations) 11/2022 - 12/2021
2	Bronchiolitis 12/2023 - 11/2022
2	Bronchiolitis Obliterans Syndrome 09/2023 - 08/2015
2	Pneumothorax 03/2022 - 12/2018
2	Airway Obstruction (Choking) 12/2018 - 01/2018
2	Exercise-Induced Asthma (Asthma, Exercise Induced) 10/2017 - 05/2013
1	Apnea 02/2023
1	Fever (Fevers) 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Mycobacterium Infections (Infections, Mycobacterium) 01/2023
1	Cholelithiasis 12/2022
1	Gallstones (Gallstone) 12/2022
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	Anaphylaxis (Anaphylactic Shock) 03/2022
1	Obesity 03/2022
1	Birth Weight (Birth Weights) 01/2021
1	Virus Diseases (Viral Diseases) 11/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019
1	Cough 11/2019
1	Neoplasms (Cancer) 11/2019
1	Osteoarthritis 04/2018
1	Bronchopulmonary Dysplasia 01/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Bronchial Spasm 09/2015
1	Allergic Bronchopulmonary Aspergillosis 03/2013
1	Hypersensitivity (Allergy) 12/2010
1	Hyperventilation 12/2010

Drug/Important Bio-Agent (IBA)

5	NitrogenIBA 12/2023 - 08/2009
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2022 - 12/2010
3	Bronchodilator Agents (Bronchodilators)IBA 03/2022 - 01/2018
2	SmokeIBA 11/2023 - 01/2021
2	ivacaftorIBA 09/2023 - 01/2017
2	lumacaftorIBA 09/2023 - 01/2017
2	C-Reactive ProteinIBA 01/2023 - 11/2022
2	Tobramycin (Nebcin)FDA LinkGeneric 11/2022 - 07/2021
2	Omalizumab (Xolair)FDA Link 08/2013 - 03/2013
2	Immunoglobulin E (IgE)IBA 08/2013 - 12/2010
2	SteroidsIBA 05/2013 - 03/2013
1	Oxygen (Dioxygen)IBA 02/2023
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2023
1	VaccinesIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	elexacaftorIBA 12/2022
1	ivacaftor drug combination tezacaftorIBA 12/2022
1	ChloridesIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Eosinophil-Derived NeurotoxinIBA 11/2022
1	Carbon MonoxideIBA 10/2022
1	Formoterol Fumarate (Oxis)FDA Link 11/2021
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2021
1	Colistin (Coly-Mycin)FDA Link 07/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2021
1	Clostridium perfringens epsilon-toxinIBA 10/2017
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2016
1	ciclesonide FDA Link 09/2015
1	Mannitol (Osmitrol)FDA LinkGeneric 02/2015
1	PowdersIBA 02/2015
1	MacrolidesIBA 08/2013
1	Theophylline (Theon)FDA LinkGeneric 08/2013
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 05/2013
1	AntibodiesIBA 12/2010
1	AllergensIBA 12/2010

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2013
2	Critical Care (Surgical Intensive Care) 12/2023 - 03/2022
1	Stem Cell Transplantation 09/2023
1	Airway Management 02/2023
1	Phage Therapy 01/2023
1	Cholecystectomy 12/2022
1	Conservative Treatment 03/2022
1	Drug Therapy (Chemotherapy) 11/2019
1	Arthroplasty 04/2018
1	Lung Transplantation 08/2015
1	Nebulizers and Vaporizers (Inhaler) 05/2013